Vav Links the T Cell Antigen Receptor to the Actin Cytoskeleton and T Cell Activation Independently of Intrinsic Guanine Nucleotide Exchange Activity
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: T cell receptor (TCR) engagement leads to formation of signaling microclusters and induction of rapid and dynamic changes in the actin cytoskeleton, although the exact mechanism by which the TCR initiates actin polymerization is incompletely understood. The Vav family of guanine nucleotide exchange factors (GEF) has been implicated in generation of TCR signals and immune synapse formation, however, it is currently not known if Vav's GEF activity is required in T cell activation by the TCR in general, and in actin polymerization downstream of the TCR in particular. METHODOLOGY/PRINCIPAL FINDINGS: Here, we report that Vav1 assembles into signaling microclusters at TCR contact sites and is critical for TCR-initiated actin polymerization. Surprisingly, Vav1 functions in TCR signaling and Ca(++) mobilization via a mechanism that does not appear to strictly depend on the intrinsic GEF activity. CONCLUSIONS/SIGNIFICANCE: We propose here a model in which Vav functions primarily as a tyrosine phosphorylated linker-protein for TCR activation of T cells. Our results indicate that, contrary to expectations based on previously published studies including from our own laboratory, pharmacological inhibition of Vav1's intrinsic GEF activity may not be an effective strategy for T cell-directed immunosuppressive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smith-Garvin, J. E., Koretzky, G. A., & Jordan, M. S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132706 · Cited by 2,144
CD28-mediated co-stimulation: a quantitative support for TCR signalling.
Acuto, O., & Michel, F. (2003) · Nature Reviews Immunology · doi:10.1038/nri1248 · Cited by 775 · cited 1×
“Of note, while previous reports indicated involvement of Vav GEF activity in CD28 signaling (reviewed in [42]), our results suggest that there may also exist a GEF-independent mechanism for Vav-mediated CD28 co-stimulation.”
ResultSignal transduction by the TCR for antigen
Kane, L. P., Lin, J., & Weiss, A. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00083-2 · Cited by 498 · cited 1×
“Subsequently, the recruitment of the adaptors LAT, GADS, and SLP-76, and enzymes such as Tec family kinases, phosphoinositol3 kinase (PI3K), and phospholipase Cc1 (PLCc1), leads to the generation of the secondary signaling intermediates, 1,4,5-inositol triphosphate (IP3) and diacylglycerol (DAG), activating intracellu…”
BackgroundCrystal structure of Rac1 in complex with the guanine nucleotide exchange region of Tiam1
Worthylake, D. K., Rossman, K. L., & Sondek, J. (2000) · Nature · doi:10.1038/35047014 · Cited by 355 · cited 1×
“Of note, we obtained similar results using another GEF-inactive form of Vav (Vav1) [59,60,61] (data not shown).”
Result
Cited by
DOCK family proteins: key players in immune surveillance mechanisms
Kunimura, K., Uruno, T., & Fukui, Y. (2020) · International Immunology · doi:10.1093/intimm/dxz067 · Cited by 96
Hem-1: putting the "WAVE" into actin polymerization during an immune response
Park, H., Chan, M. M., & Iritani, B. M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.018 · Cited by 36
The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody Production
Ushijima, M., Uruno, T., Nishikimi, A., Sanematsu, F., Kamikaseda, Y., Kunimura, K., Sakata, D., Okada, T., & Fukui, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00243 · Cited by 25
Metadata
- Authors
- Miletic, A. V., Graham, D. B., Sakata-Sogawa, K., Hiroshima, M., Hamann, M. J., Cemerski, S., Kloeppel, T., Billadeau, D. D., Kanagawa, O., Tokunaga, M., & Swat, W.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-12
- Volume
- 4
- Issue
- 8
- Pages
- e6599
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2116168075
- Cited by
- 54
- References
- 4
- FWCI
- 2.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.